HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Herpes zoster chorioretinopathy.

Abstract
Chorioretinitis and subsequent choroidal and retinal pigment epithelial atrophy following herpes zoster ophthalmicus (HZO) have rarely been reported. We report two patients, who several months following attacks of acute HZO, developed posterior fundus features of yellow, non-pigmented, punched-out areas of retinal pigment epithelial and choroidal pigment atrophy, which we have termed herpes zoster chorioretinopathy. An occlusive vasculitic process is proposed as the pathogenesis for this chorioretinopathy, and may be similar to that seen in the delayed cerebral vasculitis following HZO. A previous history of HZO should be sought in patients with a unilateral, multifocal, non-pigmented chorioretinopathy, as this may represent a characteristic delayed feature.
AuthorsT V Roberts, I C Francis, M B Kappagoda, A D Dick
JournalEye (London, England) (Eye (Lond)) Vol. 9 ( Pt 5) Pg. 594-8 ( 1995) ISSN: 0950-222X [Print] England
PMID8543079 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Inflammatory Agents
  • Prednisone
Topics
  • Aged
  • Anti-Inflammatory Agents (therapeutic use)
  • Atrophy
  • Chorioretinitis (pathology, virology)
  • Choroid (pathology)
  • Female
  • Herpes Zoster Ophthalmicus (complications, drug therapy)
  • Humans
  • Male
  • Pigment Epithelium of Eye (pathology)
  • Prednisone (therapeutic use)
  • Vasculitis (virology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: